Date Title Description PDF
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
03 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 July 2023 and 2 August 2023 Download
28 Jul 2023 On business and financial situation ROVI informs on the evaluation process to obtain marketing authorisation for Risvan® Download
05 Jul 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2023 Download
26 Jun 2023 Other relevant information The Company informs about the dividends payment Download
14 Jun 2023 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting. Download

Pages

Date Title Description PDF
06 Nov 2018 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2018 results. Download
06 Nov 2018 Información sobre resultados ROVI releases the press release related to the nine-month period ended 30 September 2018 results. Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs of the resumption of operations with own shares under the liquidity contract Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs that Jefferies International Limited has exercised, in full, the greenshoe subscription option Download
08 Oct 2018 Share capital increases and reductions Information on new shares admissions related to the capital increase of ROVI Download

Pages